Viral Infections

Infectious Disease·MeSH: Virus Diseases

11 drugs in development·9 companies·1 clinical trial

Drug Pipeline by Phase

Approved(1)

Drug	Company
banlangen granules	Fuss Brands Corp. (FBDS)

Phase 1(4)

Drug	Company
Anti-Viral Veto Cell	Cell Source, Inc. (CLCS)
DVX201 (Unmodified Natural Killer Cells)	Coeptis Therapeutics Holdings Inc. (COEP)
Influenza A/Texas/71/2017	UNITED THERAPEUTICS Corp (UTHR)
virus specific t cells	GH Research PLC (GHRS)

Preclinical(6)

Drug	Company
Anti-Rejection Anti-Viral Veto Cell	Cell Source, Inc. (CLCS)
autovac	Orgenesis Inc. (ORGS)
equivir	IMPACT BIOMEDICAL INC. (IBO)
hemopurifier	Aethlon Medical Inc. (AEMD)
nv-387-ribvp	NANOVIRICIDES, INC. (NNVC)
nv-387-rp	NANOVIRICIDES, INC. (NNVC)

BioSniper tracks 11 drugs in development for Viral Infections across 9 companies.

There are 1 clinical trial targeting Viral Infections tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.